Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Bmy save search
Global Small Molecule API Market Report 2023: Growing Demand for Small Molecule Drugs Fuels the Sector
Published: 2023-05-16 (Crawled : 23:00) - prnewswire.com
VTRS | News A | $11.355 0.93% 2.3M
|
Health Technology
|
| O: 0.44%
H: 1.8%
C: 1.2%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.28%
H: 0.17%
C: -0.5%
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: 0.06%
H: 0.43%
C: -0.79%
ALB | News | $115.52 2.88% 970K
|
Process Industries
|
| O: -0.27%
H: 2.2%
C: 1.4%
report global growing market
Global Blood Cancer Drugs Market Report 2023: Increasing Prevalence of Blood Cancer Cases Drives Growth
Published: 2023-05-16 (Crawled : 22:00) - prnewswire.com
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: -1.32%
H: 0.92%
C: -1.34%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.28%
H: 0.17%
C: -0.5%
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: 0.06%
H: 0.43%
C: -0.79%
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: -0.19%
H: 0.35%
C: 0.23%
AZN | News | $70.93 1.14% 3.8M
|
Health Technology
|
| O: 0.07%
H: 0.03%
C: -0.84%
AMGN | News | $274.12 0.81% 1.2M
|
Health Technology
|
| O: -0.82%
H: 0.03%
C: -0.44%
report cancer blood global growth market
Kronos Bio Reports Recent Business Progress and First-Quarter 2023 Financial Results
Published: 2023-05-10 (Crawled : 20:00) - globenewswire.com
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: 0.12%
H: 0.77%
C: 0.74%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.29%
H: 0.22%
C: -0.53%
KRON | $0.94 -2.08% 1.6M
|
Health Technology
|
| O: 1.66%
H: 4.35%
C: -4.35%
business financial results
Infrastructure as a Service (IaaS) Market Size is Projected to Reach USD 482 Billion by 2030, Growing at a CAGR of 25.35%: Facts & Factors
Published: 2023-05-10 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: 0.63%
H: 0.64%
C: 0.64%
ORCL | News | $115.47 0.82% 3M
|
Technology Services
|
| O: 0.68%
H: 0.91%
C: 0.75%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.09%
H: 0.48%
C: 0.28%
LLY | News | $744.47 1.8% 1M
|
Health Technology
|
| O: -0.54%
H: 2.89%
C: 2.31%
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: 0.25%
H: 1.14%
C: 0.47%
BHC | $8.565 1.36% 1.2M
|
Health Technology
|
| O: 0.68%
H: 1.53%
C: 0.85%
BABA | $72.565 2.67% 12M
|
Retail Trade
|
| O: -0.1%
H: 2.87%
C: 0.99%
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: -0.21%
H: 0.32%
C: -0.07%
MSFT | News F | $407.2 1.56% 8.5M
|
Technology Services
|
| O: 0.53%
H: 1.42%
C: 1.2%
AZN | News | $70.93 1.14% 3.8M
|
Health Technology
|
| O: -0.53%
H: 0.5%
C: 0.25%
AMGN | News | $274.12 0.81% 1.2M
|
Health Technology
|
| O: 0.2%
H: 0.05%
C: -0.33%
service reach growing market
Inhibrx Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
Published: 2023-05-08 (Crawled : 20:00) - prnewswire.com
TSVT | $4.765 2.47% 180K
|
|
| O: -0.53%
H: 2.31%
C: 0.8%
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: -0.6%
H: 0.54%
C: 0.0%
INBX | $34.37 0.79% 94K
|
Health Technology
|
| O: -2.76%
H: 5.17%
C: 2.29%
BLUE | $0.9963 4.48% 3.5M
|
Health Technology
|
| O: -3.22%
H: 22.09%
C: 16.39%
financial results
Duchenne Muscular Dystrophy Drugs Global Market Report 2023: Sector to Reach $18.1 Billion by 2030 at a 42.5% CAGR
Published: 2023-05-03 (Crawled : 18:00) - prnewswire.com
PFE | News A | $26.29 0.11% 14M
|
Health Technology
|
| O: -0.73%
H: 0.68%
C: 0.16%
LLY | News | $744.47 1.8% 1M
|
Health Technology
|
| O: 0.06%
H: 0.29%
C: -0.7%
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: -0.29%
H: 1.19%
C: 0.56%
PTCT | News S | $25.66 -1.19% 220K
|
Health Technology
|
| O: -0.38%
H: 1.38%
C: 1.2%
LXRX | $1.665 -2.63% 1.6M
|
Health Technology
|
| O: 2.19%
H: 13.21%
C: 10.0%
report reach global duchenne market
Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy
Published: 2023-05-03 (Crawled : 12:00) - biospace.com/
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: 0.34%
H: 0.6%
C: -2.47%
breyanzi approval one cell therapy
Bristol Myers Squibb to Participate in Bank of America Securities 2023 Healthcare Conference
Published: 2023-05-02 (Crawled : 13:00) - biospace.com/
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: -0.22%
H: 1.08%
C: -0.22%
america conference
Immatics Announces First Bristol Myers Squibb Opt-in of TCR-T Candidate from Ongoing Multi-target Strategic Collaboration
Published: 2023-05-01 (Crawled : 14:00) - biospace.com/
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: 0.76%
H: 2.17%
C: 1.66%
IMTX | $10.47 2.75% 220K
|
Health Technology
|
| O: 1.26%
H: 3.38%
C: 1.1%
candidate ongoing collaboration
Bristol Myers Squibb’s TRANSCEND FL and TRANSCEND NHL 001 Studies of Breyanzi in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma Meet Primary Endpoint of Overall Response Rate
Published: 2023-05-01 (Crawled : 12:00) - biospace.com/
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: 0.76%
H: 2.17%
C: 1.66%
breyanzi cell response transcend
U.S. FDA Accepts for Priority Review Supplemental Biologics License Application and EMA Validates Application for Reblozyl® (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS)
Published: 2023-05-01 (Crawled : 12:00) - biospace.com/
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: 0.76%
H: 2.17%
C: 1.66%
reblozyl fda anemia license review treatment ema application
Ayala Pharmaceuticals Announces RINGSIDE Results to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2023-04-27 (Crawled : 13:00) - biospace.com/
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.6%
ADXS | $0.572 270
|
Health Technology
|
| O: 3.39%
H: 0.0%
C: -7.38%
pharmaceuticals meeting results
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
Published: 2023-04-27 (Crawled : 12:20) - biospace.com/
TSVT | $4.765 2.47% 180K
|
|
| O: 0.71%
H: 8.58%
C: 5.64%
XYF | News | $3.882 -0.46% 310
|
Finance
|
| O: -3.13%
H: 3.23%
C: 1.94%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.17%
H: 0.31%
C: 0.06%
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.6%
financial results
Bristol Myers Squibb Strengthens Cell Therapy Capabilities by Adding New U.S. Manufacturing Facility for Viral Vector Production
Published: 2023-04-26 (Crawled : 12:00) - biospace.com/
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: -0.91%
H: 0.2%
C: -2.27%
cell therapy
Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients
Published: 2023-04-20 (Crawled : 11:00) - biospace.com/
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: -0.23%
H: 0.16%
C: -0.24%
license cancer treatment agreement
MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting
Published: 2023-04-18 (Crawled : 21:00) - mindmed.co
MNMD | $9.08 4.61% 960K
|
n/a
|
| O: -1.36%
H: 5.66%
C: 5.25%
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: 0.06%
H: 0.21%
C: -0.58%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -0.12%
H: 0.32%
C: 0.12%
INCY | $52.02 0.19% 1.2M
|
Health Technology
|
| O: -0.18%
H: 0.22%
C: 0.19%
FBRX 4 | $0.72 2.7K
|
Health Technology
|
| O: -0.94%
H: 3.81%
C: 0.95%
meeting
Regulatory Applications Accepted Across Three Regions Globally for Abecma for Earlier Use in Adults with Triple-Class Exposed Relapsed and/or Refractory Multiple Myeloma
Published: 2023-04-17 (Crawled : 18:00) - biospace.com/
TSVT | $4.765 2.47% 180K
|
|
| O: 0.32%
H: 5.03%
C: 1.82%
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: 0.21%
H: 0.25%
C: 0.0%
Foundation Medicine and Bristol Myers Squibb Expand Partnership to Focus on Companion Diagnostic Development
Published: 2023-04-11 (Crawled : 12:00) - biospace.com/
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: 0.27%
H: 0.04%
C: -0.62%
partnership diagnostic companion
Ulcerative Colitis Drug Global Market Report 2022: Increasing Prevalence of Ulcerative Colitis and Inflammatory Bowel Diseases Bolsters Sector
Published: 2023-04-07 (Crawled : 11:00) - prnewswire.com
TAK | News | $13.41 0.37% 1M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $170.2 1.38% 2M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 490
|
Health Technology
| Email alert
Add to watchlist
BHC | $8.565 1.36% 1.2M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.25 2.24% 2.6M
|
Health Technology
| Email alert
Add to watchlist
BMY | $49.225 0.17% 3.9M
|
Health Technology
| Email alert
Add to watchlist
drug report global market
Exceptional Growth in Global Anticoagulant Drugs Market Share to Gain USD 68.9 Billion By 2028: Facts & Factors
Published: 2023-04-06 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.36%
H: 2.91%
C: 2.91%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.23%
H: 0.75%
C: -0.51%
BMY | $49.225 0.17% 3.9M
|
Health Technology
|
| O: -0.19%
H: 1.97%
C: 1.51%
ABT | News | $107.91 0.78% 1.7M
|
Health Technology
|
| O: 0.27%
H: 1.01%
C: 0.42%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
global growth market
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
MTC | $2.21 41.67% 5.6M
|
Technology Services
OPRT | News | $3.12 38.67% 11M
|
Finance
PALI | $6.59 33.67% 23M
|
Manufacturing
VNRX | $0.7945 32.42% 3.1M
|
Health Technology
MLEC | $1.81 29.29% 2.8M
|
n/a
BTCM | $3.45 27.78% 640K
|
Arts, Entertainment, and Recrea...
Your saved searches
Save your searches and get alerts when important news are released.